Denali Therapeutics Inc. | ||||
NMS : DNLI || Location: United States | ||||
$20.77+0.89 (+4.48%) |
0.8 M | 19.85 - 20.92 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 8.384 M |
Feb. 29, 2024 | 8.866 M |
Feb. 15, 2024 | 10.819 M |
Jan. 31, 2024 | 9.835 M |
Jan. 12, 2024 | 9.884 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.82 | -0.86 | -4.84% |
09/30/2023 | -0.82 | -0.72 | 12.03% |
06/30/2023 | -0.70 | 1.30 | 286.35% |
03/31/2023 | -0.72 | -0.80 | -11.37% |
12/31/2022 | -0.81 | -0.75 | 6.94% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 139.160M | Shares Float | 120.034M |
Short Float | 8.384M | Market Cap | 2890.35M |
Institution ownership | 79.45% | Insider ownership | 13.851% |
Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
Trailing EPS | -1.06 | Forward EPS | -2.69 |